Holocene Advisors
GSK icon

Holocene Advisors’s GSK GSK Stock Holding History

Holocene Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,518,433
Closed -$305M – 893
2026
Q1 		$305M Sell
5,518,433
-2,598,094
-32% -$141M 0.73% 26
2025
Q4 		$398M Buy
8,116,527
+1,016,107
+14% +$47.4M 0.84% 20
2025
Q3 		$306M Buy
7,100,420
+1,490,889
+27% +$58.2M 0.7% 34
2025
Q2 		$215M Buy
5,609,531
+304,489
+6% +$11.6M 0.53% 54
2025
Q1 		$206M Buy
5,305,042
+4,792,922
+936% +$175M 0.6% 47
2024
Q4 		$17.3M Buy
512,120
+446,819
+684% +$16.1M 0.06% 265
2024
Q3 		$2.67M Sell
65,301
-5,624,394
-99% -$230M 0.01% 501
2024
Q2 		$219M Sell
5,689,695
-3,029,949
-35% -$127M 0.91% 20
2024
Q1 		$374M Buy
8,719,644
+495,096
+6% +$20.4M 1.37% 4
2023
Q4 		$305M Buy
8,224,548
+3,210,489
+64% +$115M 1.19% 8
2023
Q3 		$182M Buy
5,014,059
+2,096,223
+72% +$74.4M 0.8% 30
2023
Q2 		$104M Buy
2,917,836
+1,735,217
+147% +$62.2M 0.44% 78
2023
Q1 		$42.1M Buy
+1,182,619
New +$41.4M 0.21% 146
2022
Q3 		– Sell
-200,000
Closed -$10.9M – 861
2022
Q2 		$10.9M Buy
+200,000
New +$11M 0.07% 209

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Holocene Advisors's GSK Position: Q2 2026 in Review

Holocene Advisors sold out of GSK (GSK) in Q2 2026, closing a stake of 5,518,433 shares — an estimated $305M sold.

Holocene Advisors first reported a position in GSK in Q2 2022 and held it in 14 quarters. The position peaked at $398M in Q4 2025. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Holocene Advisors reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Holocene Advisors sold 5,518,433 GSK shares in Q2 2026, an estimated $305M.
  • Holocene Advisors first reported a position in GSK in Q2 2022 and held it in 14 quarters.
  • Holocene Advisors's GSK position peaked at $398M in Q4 2025.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.